Comparison of the effects of sumatriptan and the NK1 antagonist CP-99,994 on plasma extravasation in dura mater and c-fos mRNA expression in trigeminal nucleus caudalis of rats

This publication has 16 references indexed in Scilit:

• Inhibition by sumatriptan of central trigeminal neurones only after blood‐brain barrier disruption
  British Journal of Pharmacology, 1993
• Pharmacology of CP-99,994; a nonpeptide antagonist of the tachykinin NK1 receptor
  Regulatory Peptides, 1992
• Expression of c-fos-like immunoreactivity in brainstem after meningeal irritation by blood in the subarachnoid space
  Neuroscience, 1992
• Migraine pain associated with middle cerebral artery dilatation: reversal by sumatriptan
  The Lancet, 1991
• Stimulus-Transcription Coupling in the Nervous System: Involvement of the Inducible Proto-Oncogenes fos and jun
  Annual Review of Neuroscience, 1991
• Vasoactive peptide release in the extracerebral circulation of humans during migraine headache
  Annals of Neurology, 1990
• Sensory responses of caudal trigeminal neurons to thermal and mechanical stimuli and their behavioural correlates in the rat
  Neuroscience, 1990
• The antimigraine drug, sumatriptan (GR43175), selectively blocks neurogenic plasma extravasation from blood vessels in dura mater
  British Journal of Pharmacology, 1990
• Opening the blood–brain and blood–tumor barriers in experimental rat brain tumors: The effect of intracarotid hyperosmolar mannitol on capillary permeability and blood flow
  Annals of Neurology, 1986
• Opiate analgesics inhibit substance P release from rat trigeminal nucleus
  Nature, 1977